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INTRODUCTION
Treatment options for primary spontaneous pneumotho-
rax range from simple observation to surgery (1-3). Despite
all efforts, recurrence has always been a lingering problem,
and many intraoperative methods to induce pleural symph-
ysis have been introduced, including mechanical pleural abra-
sion, ablation with Nd:YAG laser, partial pleurectomy, and
instillation of chemical irritants (4). Nowadays, many sur-
geons perform the bleb resection with mechanical abrasion
or pleurectomy. Although these procedures report good long-
term results, there were several disadvantages (5).
In this study, we analyzed the effects of chemical pleurode-
sis after bleb resection, bullectomy or electrocoagulation for
recurrences in primary spontaneous pneumothorax as a sim-
ple alternative method of pleurectomy or pleural adhesion.
We prospectively conducted adjuvant pleurodesis with a 20%
dextrose solution or talc -20% dextrose mixed solution dur-
ing thoracoscopic procedures in patients with primary spon-
taneous pneumothorax. The effects were evaluated by com-
paring outcomes of the patients who underwent thoracoscop-
ic procedures alone with those who underwent additional
chemical pleurodesis.
MATERIALS AND METHODS
We designed the multicenter, prospective, randomized
trial under the approval of our center’s Institutional Review
Board. The allocation of the patients was conducted by the
fixed date. Informed consent was obtained from each patient
after thorough explanation. 
Between August 2003 and July 2005, 141 patients indi-
cated for surgical treatment of primary spontaneous pneu-
mothorax in two hospitals of our institute were included in
this study. A total of 141 patients, 134 males and 7 females,
ranging in age from 13 to 65 yr old (average 23.16) were
treated by video assisted thoracoscopic surgery using a 10
mm or 2 mm scope for primary spontaneous pneumothorax.
The 10-mm thoracoscopic surgeries were inclined to the
early stage of this study. Primary spontaneous pneumotho-
rax was defined as a spontaneous pneumothorax in a patient
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Effects of Additional Pleurodesis with Dextrose and Talc-Dextrose
Solution after Video Assisted Thoracoscopic Procedures for Primary
Spontaneous Pneumothorax
Recurrence after thoracoscopic surgery for primary spontaneous pneumothorax is
a lingering problem, and many intraoperative methods to induce pleural symphysis
have been introduced. We analyzed the effects of chemical pleurodesis during tho-
racoscopic procedures. Between August 2003 and July 2005, 141 patients among
indicated surgical treatment for primary spontaneous pneumothorax in two hospitals
of our institution allowed this prospective study. The patients were randomly assign-
ed to 3 groups: thoracoscopic procedure only (group A, n=50), thoracoscopic pro-
cedure and pleurodesis with dextrose solution (group B, n=49), and thoracoscopic
procedure and pleurodesis with talc-dextrose mixed solution (group C, n=42). There
was no significant difference in demographic data among the three groups. The
two groups that underwent intraoperative pleurodesis had significantly longer post-
operative hospital stays (A/B/C: 2.50± ±1.85/4.49± ±2.10/6.00± ±2.58 days; p=0.001)
and a higher incidence of postoperative fever (A/B/C: 10.0/22.45/52.38%; 
2=
21.598, p=0.00). No significant differences were found for recurrence rates or the
number of postoperative days until chest tube removal. Therefore, the results of
our study indicate that intraoperative chemical pleurodesis gives no additional advan-
tage to surgery alone in deterring recurrence for patients with primary spontaneous
pneumothorax. Thus, the use of such scarifying agents in the operating room must
be reconsidered.
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without any identifiable underlying lung disease, trauma, or
iatrogenic injury. All patients were positively identified to
have pleural/subpleural blebs by thoracoscopic examination
(with a 2-mm thoracoscope) (6) or by high-resolution com-
puted tomography. In this prospective study, the patients
were randomly assigned to 3 different groups by two sur-
geons: thoracoscopic bleb resection or electrical coagulation
(TBR) only (50 patients; group A), TBR and pleurodesis with
a 20% dextrose solution (200 cc) (49 patients; group B), and
TBR and pleurodesis with a talc (2 g of asbestos free steril-
ized talc powder) -20% dextrose mixed solution (200 cc)
(42 patients; group C).
In the early stage of this study, 31 operations were per-
formed with a 10-mm thoracoscope, but all remaining 110
consecutive operations were performed by needlescopy (2-mm
thoracoscopy) (7). According to their assigned groups, the
patients received adjuvant pleurodesis after resection of blebs
with mechanical suturing devices. The chemicals were in-
stilled into the pleural cavity, mainly at the thoracoscopic
procedure sites and apex of the lungs. In group C, talc pow-
der was mixed with the dextrose solution to form a slurry
before instillation. The solutions were allowed to drain freely
after the patient was transferred to the general ward (aver-
age time of pleurodesis, 2 hr). No form of mechanical pleu-
ral abrasion was conducted in any of the patients. Postoper-
ative pain was managed by oral nonsteroidal anti-inflamma-
tory drugs (NSAIDs) and intermittent parenteral NSAIDs
and meperidine for break-through pain. Patients were dis-
charged 2 days after chest tube removal according to our insti-
tutional protocol.
Postoperative data was recorded included recurrence of
pneumothorax, postoperative hospital stay, days until chest tube
removal, occurrence of postoperative fever, and frequency of
parenteral analgesics use. Patients follow-up was conducted
by outpatient clinic visits and telephone interviews. Statis-
tical analysis was done using SPSS for Windows (Ver. 10.0.7.,
Chicago, IL, U.S.A.). Analysis of variance (ANOVA) was
used to compare patient characteristics, postoperative hospi-
tal stay, days until chest tube removal, and chest tube drainage
amount. Chi-square test was used to compare categorical
variables. All p values <0.05 were considered statistically
significant.
RESULTS
Patient characteristics are summarized in Table 1. The
mean ages of patients were 22.26 yr for group A, 24.18 for
group B, and 23.02 for group C. There were 46 males and
4 females in group A, 46 males and 3 females in group B,
and 42 males and no females in group C. The three groups
did not differ significantly in age, sex, or surgical approach.
There were no operative deaths, and all procedures were
uneventful. No patient underwent conversion to open tho-
racotomy.
Postoperative data are summarized in Table 2. Days until
chest tube removal were 2.96±1.56 days for group A, 2.95
±2.31 for group B, and 3.60±1.65 for group C (p=0.188)
and did not differ significantly. Postoperative hospital stay
and frequency of parenteral analgesics use per patient differed
significantly among the 3 groups. The durations of postopera-
tive hospital stay (days) were 2.50±1.85 in group A, 4.49
±2.10 in group B, and 6.00±2.58 in group C (p=0.001),
and frequencies of parenteral analgesics use per patient were
2.37±3.51 for group A, 3.42±3.48 for group B, and 5.02
±2.72 for group C (p=0.001). Post hoc studies (Duncan)
showed that group C differed significantly from group A
and B in postoperative stay and parenteral analgesics use.
A (total N=50) Group B (total N=49) C (total N=42) Signif
Operation methods TBR Only TBR with 20% dextrose TBR with talc-20% dextrose
Male:female 46 (92%):4 (8%) 46 (93.9%):3 (6.1%) 42 (100%):0 (0%) NS
Mean age (Range: yr) 22.26 (13-36) 24.18 (16-45) 23.02 (15-65) NS
Site (right:left) 24 (48%):26 (52%) 23 (46.9%):26 (53.1%) 18 (42.9%):24 (57.1%) NS
Table 1. Patient characteristics
N, number of patients; Signif, statistical significance; NS, not significant.
TBR Only, thoracoscopic procedures without chemical pleurodesis; TBR with 20% dextrose, thoracoscopic procedures and chemical pleurodesis
with a 20% dextrose solution; TBR with talc-20% dextrose, thoracoscopic procedures and chemical pleurodesis with a talc-20% dextrose solution.
A (total N=50) Group B (total N=49) C (total N=42) p value
Postoperative chest drainage (days) 2.96±1.56 2.95±2.31 3.60±1.65 0.188
Postoperative hospital stay (days) 4.50±1.85 4.49±2.10 6.00±2.58* 0.001
�
Parenteral analgesics (frequencies/patient) 2.37±3.51 3.42±3.48 5.02±2.72* 0.00
�
Rate of fever (>37.5°C) 10% (N=5) 22.45% (N=11) 52.38% (N=22) 0.0
�
Recurrence rate 6% (N=3) 2.04% (N=1) 2.38% (N=1) 0.504
Table 2. Postoperative data
N, number of patients. *, Significantly different group according to post hoc studies; 
�
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Five patients in group A, 11 in group B, and 22 in group C
experienced postoperative fever ( 2=21.598, p=0.00), show-
ing a significant difference. 
Mean follow-up durations were 20.22±9.71 months in
group A, 23.65±2.51 months in group B, and 17.93±
3.64 months in group C. During follow-up, recurrent ipsi-
lateral pneumothorax was noted in 5 of the 141 patients (3.54
%); 3 in group A (6.0%), 1 in group B (2.04%), and 1 in
group C (2.38%). There was no statistically significant dif-
ference in recurrence rates among the three groups ( 2=1.372,
p=0.54). Of the 5 patients with ipsilateral recurrence, 2 under-
went reoperation by video-assisted thoracoscopic surgery
(VATS), 2 were treated by chest tube drainage, and 1 patient
received conservative management with inhaled oxygen. 
DISCUSSION
VATS is currently well accepted as a safe and effective pro-
cedure for the management of primary spontaneous pneu-
mothorax. After resection or ligation of blebs and elctro-
caogulation of subpleural blebs many adjuvant procedures
have been used to achieve pleural symphysis in order to fur-
ther reduce recurrence rates. Partial pleurectomy and pleu-
ral abrasion have shown recurrence rates of 2-4.4% (8, 9) and
3-3.6% (10, 11), respectively. Chemical pleurodesis has also
been tried with talc, and minocycline and have shown recur-
rence rates of 1.73-5% (12, 13) and 2.9% (14), respectively.
Other reported methods include electrocoagulation of the pleu-
ra and ablation with Nd:YAG laser.
At our institution, VATS is conducted for pneumothorax
with a 2-mm thoracoscope and instruments from 2003. Sur-
gical staplers are introduced via the 11.5 mm trocar site at
the thoracostomy wound, which most of the patients already
have before the operation. Although a recent study by Chang
(15) showed a higher rate of recurrence by needlescopic VATS
(procedure using instruments with an external diameter ≤3
mm [7]) compared to the same procedures performed by con-
ventional VATS, our experience shows that recurrence rates
are comparable to conventional VATS (16-19). We hypothe-
sized that additional chemical pleurodesis may further decrease
recurrence rates after bleb resection. 
The selection of the agents for chemical pleurodesis was
based on their low cost, ease of administration, and reported
high effectiveness (20-22). Our results show that 20% dex-
trose solution and talc are effective in reducing recurrence
rates, showing comparable recurrence rates with those of pre-
vious studies with other agents in the literature. However,
there is still much concerns in regards to acute and chronic
side effects of talc. During this study, we did not experience
any cases of postoperative empyema, arrhythmia, or respira-
tory failure, all of which have been reported in the literature
(23). Although chemical pleurodesis did not increase the
duration of postoperative chest drainage, a significantly greater
number of patients with fever was noted and due to more
frequent chest pain more parenteral analgesics was used in
the pleurodesis groups, especially the talc group. There is
also the issue of possible oncogenic risk and difficulty in per-
forming future thoracoscopy or thoracotomy caused by the
creation of tight adhesions (11). 
Our results showed that VATS procedures for primary spon-
taneous pneumothorax are safe and effective. However, we
feel that practice of additional chemical pleurodesis for deter-
ring recurrence should be reconsidered. Chest pain and fever
associated with this procedure may cause unnecessary suffer-
ing for the patients and extension of postoperative hospital stay.
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